rs6955597
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_006080.3(SEMA3A):c.333+92G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00201 in 997,558 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0066 ( 13 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 4 hom. )
Consequence
SEMA3A
NM_006080.3 intron
NM_006080.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -5.81
Publications
1 publications found
Genes affected
SEMA3A (HGNC:10723): (semaphorin 3A) This gene is a member of the semaphorin family and encodes a protein with an Ig-like C2-type (immunoglobulin-like) domain, a PSI domain and a Sema domain. This secreted protein can function as either a chemorepulsive agent, inhibiting axonal outgrowth, or as a chemoattractive agent, stimulating the growth of apical dendrites. In both cases, the protein is vital for normal neuronal pattern development. Increased expression of this protein is associated with schizophrenia and is seen in a variety of human tumor cell lines. Also, aberrant release of this protein is associated with the progression of Alzheimer's disease. [provided by RefSeq, Jul 2008]
SEMA3A Gene-Disease associations (from GenCC):
- skeletal dysplasiaInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- hypogonadotropic hypogonadism 16 with or without anosmiaInheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- multiple congenital anomalies/dysmorphic syndromeInheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Kallmann syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.04).
BP6
Variant 7-84129031-C-A is Benign according to our data. Variant chr7-84129031-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1208050.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00658 (1001/152046) while in subpopulation AFR AF = 0.0207 (860/41480). AF 95% confidence interval is 0.0196. There are 13 homozygotes in GnomAd4. There are 463 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SEMA3A | NM_006080.3 | c.333+92G>T | intron_variant | Intron 3 of 16 | ENST00000265362.9 | NP_006071.1 | ||
| SEMA3A | XM_005250110.4 | c.333+92G>T | intron_variant | Intron 6 of 19 | XP_005250167.1 | |||
| SEMA3A | XM_047419751.1 | c.333+92G>T | intron_variant | Intron 7 of 20 | XP_047275707.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SEMA3A | ENST00000265362.9 | c.333+92G>T | intron_variant | Intron 3 of 16 | 1 | NM_006080.3 | ENSP00000265362.3 | |||
| SEMA3A | ENST00000436949.5 | c.333+92G>T | intron_variant | Intron 4 of 17 | 5 | ENSP00000415260.1 | ||||
| SEMA3A | ENST00000420047.1 | c.333+92G>T | intron_variant | Intron 4 of 4 | 4 | ENSP00000391900.1 |
Frequencies
GnomAD3 genomes AF: 0.00654 AC: 994AN: 151928Hom.: 13 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
994
AN:
151928
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00119 AC: 1006AN: 845512Hom.: 4 AF XY: 0.00115 AC XY: 509AN XY: 443902 show subpopulations
GnomAD4 exome
AF:
AC:
1006
AN:
845512
Hom.:
AF XY:
AC XY:
509
AN XY:
443902
show subpopulations
African (AFR)
AF:
AC:
393
AN:
20826
American (AMR)
AF:
AC:
117
AN:
40784
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
21064
East Asian (EAS)
AF:
AC:
2
AN:
36122
South Asian (SAS)
AF:
AC:
164
AN:
69784
European-Finnish (FIN)
AF:
AC:
0
AN:
50284
Middle Eastern (MID)
AF:
AC:
19
AN:
4510
European-Non Finnish (NFE)
AF:
AC:
199
AN:
562342
Other (OTH)
AF:
AC:
112
AN:
39796
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
43
85
128
170
213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00658 AC: 1001AN: 152046Hom.: 13 Cov.: 32 AF XY: 0.00623 AC XY: 463AN XY: 74336 show subpopulations
GnomAD4 genome
AF:
AC:
1001
AN:
152046
Hom.:
Cov.:
32
AF XY:
AC XY:
463
AN XY:
74336
show subpopulations
African (AFR)
AF:
AC:
860
AN:
41480
American (AMR)
AF:
AC:
85
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
10
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10546
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
36
AN:
67974
Other (OTH)
AF:
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
51
102
152
203
254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3476
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Feb 14, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.